Price $1.19 |
Market Cap
57.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.44
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-116.3K
|
FCF
-2.2
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-75.50%
|
ROI
-40.70%
|
|
ROA
-64.90%
|
EPS Growth
-644.40%
|
Current Ratio
10.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Acorda Therapeutics Inc (ACOR) | $0.94 | - | - | 16.2M | Strong Buy |
| Akebia Therapeutics Inc (AKBA) | $0.67 | - | - | 93M | Strong Buy |
| Akumin Inc (AKU) | $0.97 | - | - | 62.6M | Strong Buy |
| Alimera Sciences Inc (ALIM) | $2.61 | - | - | 17.3M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $2.14 | - | - | 604.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
